Efficacy and safety of direct-acting antiviral therapy in previous hard-to-treat patients with recurrent hepatitis C virus infection after liver transplantation: a real-world cohort

BACKGROUND: Recurrent hepatitis C virus (HCV) infection after liver transplantation (LT) has been a frequent and relevant problem in the past two decades. This analysis evaluated the efficacy and safety of new interferon (IFN)-free direct-acting antiviral (DAA) therapies in a large real-world cohort...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Drug Des Devel Ther
Glavni autori: Bernuth, Sebastian, Grimm, Daniel, Vollmar, Johanna, Darstein, Felix, Mittler, Jens, Heise, Michael, Hoppe-Lotichius, Maria, Galle, Peter R, Lang, Hauke, Zimmermann, Tim
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2017
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5513830/
https://ncbi.nlm.nih.gov/pubmed/28744104
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S139837
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items